Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV3 | Q8NET8 | 14/20 | 0.45 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12539005 | 0.86 | TRPV3 (0.43) | TRPV3KIF11MAOB | |
| SCHEMBL12538116 | 0.83 | RAB9A (0.40) | TRPV3MAOB | |
| SCHEMBL12538599 | 0.82 | CTSS (0.49) | TRPV3MAOB | |
| SCHEMBL12537989 | 0.80 | TRPV3 (0.50) | TRPV3 | |
| SCHEMBL12538147 | 0.80 | TRPV3 (0.46) | TRPV3MAOB | |
| SCHEMBL20209738 | 0.77 | TRPV3 (0.38) | TRPV3LTA4HKIF11MAOB | |
| SCHEMBL12538059 | 0.75 | TRPV3 (0.44) | TRPV3KIF11 | |
| SCHEMBL12538047 | 0.75 | TRPV3 (0.51) | TRPV3 | |
| SCHEMBL1549511 | 0.74 | RAD51 (0.41) | TRPV3LTA4HKIF11GSTO1 | |
| SCHEMBL12537708 | 0.73 | TRPV3 (0.40) | TRPV3MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9012651-B2 | TRPV3 modulators | ABBVIE INC. (US) | 2015-04-21 | — | — | US | disclosed |
| WO-2012129491-A1 | TRPV3 MODULATORS | ABBOTT LABORATORIES (US) | 2012-09-27 | — | — | WO | disclosed |
| US-20120245124-A1 | TRPV3 Modulators | ABBOTT LABORATORIES (US) | 2012-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120245124-A1 | TRPV3 Modulators | TRPV3, TRPV2, TRPV1 | TRPV3 1/4885LTA4H 679/4885KIF11 4349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.